TREAT - 医索

LBA292 Zolbetuximab + mFOLFOX6 as first-line (1L) treatment for patients (pts) withclaudin-18.2

医客学院 - 会议报告集

Efficacy and safety of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated

医客学院 - 会议报告集

Does neoadjuvant treatment in resectable pancreatic cancer improve disease outcomes Systematic review and metanalysis of randomized

医客学院 - 会议报告集

Do nonoperative modality (NOM) treatments of rectal cancer compromise the chance of cure Final surgical salvage results from OPERA p

医客学院 - 会议报告集

Clinical and radiological response to locoregional and systemic treatments in well differentiated gastroenteropancreatic

医客学院 - 会议报告集

Circulating tumor DNA (ctDNA) for response assessment in patients with anal cancer treated with definitive chemoradiation

医客学院 - 会议报告集

Analysis of the treatment outcome of ampulla of Vater carcinoma and the usefulness of

医客学院 - 会议报告集

学术成果“开年红”！针灸科一孕晚期贝尔麻痹病例获SCI期刊报道

刚踏入2023年不久我院科研领域便迎来好消息老锦雄佛山市名中医传承工作室发表的学术论文第4次获SCI收录的期刊报道再次凸显该科的技术实力及科研水平1月4日，《Acupuncturetreatment of a pregnant patient with Bell's palsy in the .....

学术资讯 - 医学科普

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer in CheckMate 227

DISCLAIMER: This is a PDF file of an unedited manuscript that has been accepted for publication. As aservice to our subscribers we are providing this early version of the article. The paper will be copy editedand typeset.....

医客学院

【重磅】《柳叶刀•感染病学》：COX-2抑制剂塞来昔布是新冠阳性患者早期症状居家管理首选药物

近期，一篇题为“Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents ”的文章重磅发布于世界顶尖的感染病学期刊《The Lancet Infectious Diseases》，该杂志影响因子高达71.42.......

学术资讯 - 新冠药物